Belief BioMed gains Macao approval for hemophilia B gene therapy
March 20, 2026 | 11:51
The Chinese biotech company received regulatory clearance for its BBM-H901 treatment, marking the country's inaugural gene therapy for the bleeding disorder.
Mobile Version